secwatch.observer — SEC 8-K summary
======================================

Issuer:     Travere Therapeutics, Inc. (TVTX)
CIK:        0001438533
Form:       8-K
Filed at:   2023-09-05T23:59:59+00:00
Accession:  0001193125-23-228130
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Travere closes $210M asset sale to Mirum; eligible for up to $235M in milestones
--------------------------------------------------------------------------------

- Upfront cash payment of $210M from Mirum for Chenodal and Cholbam assets.
- Potential milestone payments up to $235M based on annual net sales tiers ($125M-$500M).
- Transaction closed on August 31, 2023, as previously announced on July 16, 2023.
- Pro forma financial statements to be filed by amendment within four business days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438533/000119312523228130/0001193125-23-228130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438533/000119312523228130/d548855d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-228130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer